One patent covers implantable devices made with a thermoplastic polymer such as polyetheretherketone, at least one region with interconnected porosity and bioactive particles, according to a news release. The other protects a manufacturing process for implants involving thermoplastic polymers with regions of differing porosity.
Happe’s proprietary material has interconnected, cancellous porosity and bioactive surfaces with exposed hydroxyapatite for bone in-growth and on-growth.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
